Trials / Completed
CompletedNCT02020967
Programme of Acromegaly Screening in Patients With Associated Somatic Disorders
Programme of Acromegaly Screening in Patients With Associated Somatic Disorders, Who Are Observed at the Moscow Board of Health Endocrinology Dispensary and Endocrinology Hospital at First Moscow State Medical University for the Purpose of Early Identification of the Disease.
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 367 (actual)
- Sponsor
- Ipsen · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The primary objective of the protocol is to define percentage of patients with acromegaly in relation to the total number of screened patients with confirmed clinically significant set of associated somatic disorders with the help of laboratory (Insulin-like Growth Factor I, Growth Hormone, Oral Glucose-Tolerance Test \[IGF-1, GH, OGTT\]) and instrumental examination methods (Magnetic Resonance Imaging \[MRI\]).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Non-interventional cross-sectional survey | This is a survey which does not involve any intervention into routine clinical practice, including the use of any investigational therapy or special examination methods. |
Timeline
- Start date
- 2013-12-05
- Primary completion
- 2015-09-15
- Completion
- 2015-09-15
- First posted
- 2013-12-25
- Last updated
- 2021-05-26
- Results posted
- 2021-04-28
Locations
2 sites across 1 country: Russia
Source: ClinicalTrials.gov record NCT02020967. Inclusion in this directory is not an endorsement.